Invention Grant
US08815856B2 Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
有权
（3R，6R）-3-（2,3-二氢-1H-茚-2-基）-1 - [（1R）-1-（2,6-二甲基-3-吡啶基）-2- （4-吗啉基）-2-氧代乙基] -6 - [（1S）-1-甲基丙基] -2,5-哌嗪二酮
![Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione](/docs/US/2014-08-26/US08815856B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
- Patent Title (中): （3R，6R）-3-（2,3-二氢-1H-茚-2-基）-1 - [（1R）-1-（2,6-二甲基-3-吡啶基）-2- （4-吗啉基）-2-氧代乙基] -6 - [（1S）-1-甲基丙基] -2,5-哌嗪二酮
-
Application No.: US14217938Application Date: 2014-03-18
-
Publication No.: US08815856B2Publication Date: 2014-08-26
- Inventor: Richard Bellingham , Andrew Mark Buswell , Victoria Ironmonger , Michael Urquhart
- Applicant: Glaxo Group Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: Glaxo Group Limited
- Current Assignee: Glaxo Group Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Kathryn L. Coulter; Tony W. Peng
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D413/14 ; C07D401/06
![Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione](/abs-image/US/2014/08/26/US08815856B2/abs.jpg.150x150.jpg)
Abstract:
Disclosed are crystalline forms of (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione benzenesulfonate salt and pharmaceutical compositions thereof. Also disclosed are processes for the preparation the above compounds and methods for use thereof.
Public/Granted literature
Information query
